BACKGROUND: Autosomal recessive cerebellar ataxias (ARCA) are a complex group of neurodegenerative disorders with high clinical and genetic heterogeneity. In most cases, the cerebellar ataxia is not pure, and complicating clinical features such as pyramidal signs or extraneurological features are found. OBJECTIVE: To identify the genetic origin of the cerebellar ataxia for 3 consanguineous North African families presenting with ARCA. METHODS: Genome-wide high-density SNP genotyping and whole-exome sequencing were performed followed by Sanger sequencing for mutation confirmation. RESULTS: Two variants were identified in SLC25A46. Mutations in this gene have been previously associated with Charcot-Marie-Tooth type 2 and optic atrophy. While the previously reported variant p.Arg340Cys seems to be consistently associated with the same clinical features such as childhood onset, optic atrophy, gait and speech difficulties, and wasting of the lower limbs, the patient with the novel mutation p.Trp160Ser did not present with optic atrophy and his ocular abnormalities were limited to nystagmus and saccadic pursuit. CONCLUSION: In this study, we report a novel variant (p.Trp160Ser) in SLC25A46 and we broaden the phenotypic spectrum associated with mutations in SLC25A46.
BACKGROUND:Autosomal recessive cerebellar ataxias (ARCA) are a complex group of neurodegenerative disorders with high clinical and genetic heterogeneity. In most cases, the cerebellar ataxia is not pure, and complicating clinical features such as pyramidal signs or extraneurological features are found. OBJECTIVE: To identify the genetic origin of the cerebellar ataxia for 3 consanguineous North African families presenting with ARCA. METHODS: Genome-wide high-density SNP genotyping and whole-exome sequencing were performed followed by Sanger sequencing for mutation confirmation. RESULTS: Two variants were identified in SLC25A46. Mutations in this gene have been previously associated with Charcot-Marie-Tooth type 2 and optic atrophy. While the previously reported variant p.Arg340Cys seems to be consistently associated with the same clinical features such as childhood onset, optic atrophy, gait and speech difficulties, and wasting of the lower limbs, the patient with the novel mutation p.Trp160Ser did not present with optic atrophy and his ocular abnormalities were limited to nystagmus and saccadic pursuit. CONCLUSION: In this study, we report a novel variant (p.Trp160Ser) in SLC25A46 and we broaden the phenotypic spectrum associated with mutations in SLC25A46.
Authors: Matthis Synofzik; Michael A Gonzalez; Charles Marques Lourenco; Marie Coutelier; Tobias B Haack; Adriana Rebelo; Didier Hannequin; Tim M Strom; Holger Prokisch; Christoph Kernstock; Alexandra Durr; Ludger Schöls; Marcos M Lima-Martínez; Amjad Farooq; Rebecca Schüle; Giovanni Stevanin; Wilson Marques; Stephan Züchner Journal: Brain Date: 2013-12-19 Impact factor: 13.501
Authors: Kaisu Nikali; Anu Suomalainen; Juha Saharinen; Mikko Kuokkanen; Johannes N Spelbrink; Tuula Lönnqvist; Leena Peltonen Journal: Hum Mol Genet Date: 2005-08-31 Impact factor: 6.150
Authors: A Mégarbané; V Delague; M M Ruchoux; E Rizkallah; C A Maurage; L Viollet; N Rouaix-Emery; A Urtizberea Journal: Am J Med Genet Date: 2001-06-15
Authors: M B Hammer; G Eleuch-Fayache; J R Gibbs; S K Arepalli; S B Chong; C Sassi; Y Bouhlal; F Hentati; R Amouri; A B Singleton Journal: Eur J Neurol Date: 2012-10-09 Impact factor: 6.089
Authors: Alexander J Abrams; Robert B Hufnagel; Adriana Rebelo; Claudia Zanna; Neville Patel; Michael A Gonzalez; Ion J Campeanu; Laurie B Griffin; Saskia Groenewald; Alleene V Strickland; Feifei Tao; Fiorella Speziani; Lisa Abreu; Rebecca Schüle; Leonardo Caporali; Chiara La Morgia; Alessandra Maresca; Rocco Liguori; Raffaele Lodi; Zubair M Ahmed; Kristen L Sund; Xinjian Wang; Laura A Krueger; Yanyan Peng; Carlos E Prada; Cynthia A Prows; Elizabeth K Schorry; Anthony Antonellis; Holly H Zimmerman; Omar A Abdul-Rahman; Yaping Yang; Susan M Downes; Jeffery Prince; Flavia Fontanesi; Antonio Barrientos; Andrea H Németh; Valerio Carelli; Taosheng Huang; Stephan Zuchner; Julia E Dallman Journal: Nat Genet Date: 2015-07-13 Impact factor: 38.330
Authors: Monia B Hammer; Ghada Eleuch-Fayache; Lucia V Schottlaender; Houda Nehdi; J Raphael Gibbs; Sampath K Arepalli; Sean B Chong; Dena G Hernandez; Anna Sailer; Guoxiang Liu; Pramod K Mistry; Huaibin Cai; Ginamarie Shrader; Celeste Sassi; Yosr Bouhlal; Henry Houlden; Fayçal Hentati; Rim Amouri; Andrew B Singleton Journal: Am J Hum Genet Date: 2013-01-17 Impact factor: 11.025
Authors: Marie Coutelier; Monia B Hammer; Giovanni Stevanin; Marie-Lorraine Monin; Claire-Sophie Davoine; Fanny Mochel; Pierre Labauge; Claire Ewenczyk; Jinhui Ding; J Raphael Gibbs; Didier Hannequin; Judith Melki; Annick Toutain; Vincent Laugel; Sylvie Forlani; Perrine Charles; Emmanuel Broussolle; Stéphane Thobois; Alexandra Afenjar; Mathieu Anheim; Patrick Calvas; Giovanni Castelnovo; Thomas de Broucker; Marie Vidailhet; Antoine Moulignier; Robert T Ghnassia; Chantal Tallaksen; Cyril Mignot; Cyril Goizet; Isabelle Le Ber; Elisabeth Ollagnon-Roman; Jean Pouget; Alexis Brice; Andrew Singleton; Alexandra Durr Journal: JAMA Neurol Date: 2018-05-01 Impact factor: 18.302
Authors: Marie Beaudin; Antoni Matilla-Dueñas; Bing-Weng Soong; Jose Luiz Pedroso; Orlando G Barsottini; Hiroshi Mitoma; Shoji Tsuji; Jeremy D Schmahmann; Mario Manto; Guy A Rouleau; Christopher Klein; Nicolas Dupre Journal: Cerebellum Date: 2019-12 Impact factor: 3.847
Authors: Elena Buglo; Evan Sarmiento; Nicole Belliard Martuscelli; David W Sant; Matt C Danzi; Alexander J Abrams; Julia E Dallman; Stephan Züchner Journal: PLoS One Date: 2020-03-24 Impact factor: 3.240